1. Home
  2. Analysis
  3. Mycophenolate-mofetil
  4. Bone-marrow-toxicity

Mycophenolate mofetil and Bone marrow toxicity - a phase IV clinical study of FDA data

Summary:

Bone marrow toxicity is reported as a side effect among people who take Mycophenolate mofetil (mycophenolate mofetil), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Foscavir, and have Oral candidiasis.

The phase IV clinical study analyzes which people have Bone marrow toxicity when taking Mycophenolate mofetil. It is created by eHealthMe based on reports of 93,176 people who have side effects when taking Mycophenolate mofetil from the FDA, and is updated regularly.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,461 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

What is Bone marrow toxicity?

Bone marrow toxicity (decrease in cells responsible for providing immunity, carrying oxygen, and those responsible for normal blood clotting) is found to be associated with 170 drugs and 376 conditions by eHealthMe. Check the latest studies of Bone marrow toxicity.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

93,176 people reported to have side effects when taking Mycophenolate mofetil.
Among them, 68 people (0.07%) have Bone marrow toxicity.

Could Mycophenolate mofetil cause Bone marrow toxicity?

Among these 68 people:

How long have people been on Mycophenolate mofetil when they have Bone marrow toxicity? *

  • < 1 month: 53.85 %
  • 1 - 6 months: 38.46 %
  • 6 - 12 months: 7.69 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Bone marrow toxicity when taking Mycophenolate mofetil? *

  • female: 78.43 %
  • male: 21.57 %

What is the age of people who have Bone marrow toxicity when taking Mycophenolate mofetil? *

  • 0-1: 0.0 %
  • 2-9: 8.16 %
  • 10-19: 0.0 %
  • 20-29: 40.82 %
  • 30-39: 6.12 %
  • 40-49: 4.08 %
  • 50-59: 28.57 %
  • 60+: 12.24 %

What are other drugs people take besides Mycophenolate mofetil? *

  1. Posaconazole: 13 people, 19.12%
  2. Foscavir: 13 people, 19.12%
  3. Tacrolimus: 12 people, 17.65%
  4. Ursodeoxycholic Acid: 11 people, 16.18%
  5. Ceftriaxone: 9 people, 13.24%
  6. Ganciclovir: 8 people, 11.76%
  7. Vancomycin: 7 people, 10.29%
  8. Prednisone: 6 people, 8.82%
  9. Methylprednisolone: 6 people, 8.82%
  10. Rapamune: 6 people, 8.82%

What are other side effects people have besides Bone marrow toxicity? *

  1. Cytomegalovirus Infection: 22 people, 32.35%
  2. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 21 people, 30.88%
  3. Oral Candidiasis (fungal infection of mouth): 19 people, 27.94%
  4. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 18 people, 26.47%
  5. Hepatic Failure (liver failure): 13 people, 19.12%
  6. Adenoviral Hepatitis (viral hepatitis): 13 people, 19.12%
  7. Diarrhea: 13 people, 19.12%
  8. Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 13 people, 19.12%
  9. Hepatic Necrosis (large portions of liver die off due to severe liver disease): 13 people, 19.12%
  10. Hepatocellular Injury (liver injury): 13 people, 19.12%

What are the existing conditions these people have? *

  1. Oral Candidiasis (fungal infection of mouth): 19 people, 27.94%
  2. Cytomegalovirus Infection: 14 people, 20.59%
  3. Bone Marrow Conditioning Regimen: 13 people, 19.12%
  4. Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 11 people, 16.18%
  5. Escherichia Infection (bacterial infection by escherichia coli): 5 people, 7.35%
  6. Thrombotic Microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury): 5 people, 7.35%
  7. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 5.88%
  8. Nausea (feeling of having an urge to vomit): 3 people, 4.41%
  9. Nephropathy (damage to or disease of a kidney): 3 people, 4.41%
  10. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 4.41%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and have Bone marrow toxicity?

- Check whether Bone marrow toxicity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mycophenolate mofetil:

Bone marrow toxicity treatments and more:

How severe was Bone marrow toxicity and when was it recovered:

Expand to all the drugs that have ingredients of mycophenolate mofetil:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mycophenolate mofetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bone marrow toxicity:

Browse all the conditions that are associated with Bone marrow toxicity:

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Mycophenolate mofetil) and Mycophenolate mofetil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.